Últimas subidas - Macular Diseases - Acquired
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 117 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 97 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 106 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 48 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 51 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 62 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 64 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 67 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 48 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 56 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 54 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 56 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 57 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicityvista 58 veces77 year old female who had been on Elmiron for 20 years and stopped it 2 years agoMarzo 15, 2026
|
|
MacTel with foveal atrophy in both eyesvista 44 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 42 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 38 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 43 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 46 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 45 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 45 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 44 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 45 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 45 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 47 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 45 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 53 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 42 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
MacTel with foveal atrophy in both eyesvista 51 veces62 year old female with 20/50 OD, 20/40 OS.Febrero 18, 2026
|
|
Latanoprost induced CMEvista 60 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 72 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 66 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 59 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 66 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 70 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 62 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 84 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 59 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 58 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 67 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 74 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Latanoprost induced CMEvista 69 veces89 year old man with CME from latanoprost that cleared within one month of stopping the medicationNoviembre 23, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 85 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 80 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 76 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 77 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 72 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 77 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 75 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 63 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 72 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 65 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 78 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 65 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 91 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 67 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 73 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 58 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 78 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Hydroxychloroquine Toxicityvista 105 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 128 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 126 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 129 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 116 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 108 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 103 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 137 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 146 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Hydroxychloroquine Toxicityvista 111 veces60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OSDiciembre 22, 2024
|
|
Pseudophakic CME chronicvista 96 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 99 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 117 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 126 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 116 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 110 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 119 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 119 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 103 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 102 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 119 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 108 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 100 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 102 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 127 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 102 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 103 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 107 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 125 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 138 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 113 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Pseudophakic CME chronicvista 107 veces74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/TimololNoviembre 06, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 121 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 116 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 120 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 115 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 96 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 97 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 91 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 112 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevista 96 veces60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSSeptiembre 17, 2024
|
|
| 2319 archivos en 24 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
